feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Gabapentin: The Double-Edged Sword of Pain Relief

Gabapentin: The Double-Edged Sword of Pain Relief

27 Jan

Summary

  • Gabapentin treats seizures and nerve pain but carries risks.
  • Misuse rates for gabapentin prescriptions range from 40% to 65%.
  • Combining gabapentin with depressants can be fatal.
Gabapentin: The Double-Edged Sword of Pain Relief

Gabapentin, initially developed for seizures, has become a widely prescribed medication for various pain conditions, including neuropathic pain, diabetic neuropathy, and restless legs syndrome.

Its mechanism involves reducing nerve signaling, effectively calming abnormal nervous system activity. Beyond its FDA-approved uses for epilepsy and postherpetic neuralgia, gabapentin is frequently prescribed off-label for conditions like back pain, fibromyalgia, and agitation in dementia.

One of its key advantages is treating neuropathic pain, which often resists conventional painkillers. It also offers a safer alternative to opioids as it does not suppress breathing and is not metabolized by the liver.

However, gabapentin is associated with significant risks, including high misuse rates between 40% and 65%. It can also be habit-forming and is now classified as a controlled substance in several U.S. states.

Potential side effects, particularly in older adults, include sedation, dizziness, confusion, and falls. Combining gabapentin with other central nervous system depressants like opioids or alcohol can lead to severe respiratory depression and death.

Safe use necessitates taking the medication exactly as prescribed, avoiding unapproved drug combinations, and consulting a healthcare provider before altering dosage or discontinuing the drug to prevent withdrawal symptoms.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Gabapentin is prescribed for seizures, neuropathic pain like that from shingles or diabetes, and restless legs syndrome, among other off-label uses.
Key risks include high misuse rates, potential for habit formation, side effects like sedation and confusion, and dangerous interactions when combined with other depressants.
Safe usage involves taking it exactly as prescribed, avoiding alcohol and unapproved drug combinations, and consulting a doctor before changing the dose or stopping the medication.

Read more news on

Healthside-arrow
•
trending

Padma Awards: Unsung heroes honoured

trending

Mumbai Metro Line 11

trending

Border 2 box office success

trending

Australian Open Heat Suspends Play

trending

MPESB Police Answer Key 2026

trending

Arne Slot on Mo Salah

trending

BBL 2026 Qualifier prediction

trending

Man wins £79,000 Range Rover

trending

Samsung Galaxy S26 Ultra

You may also like

Drug Repurposed: From Alcohol to Addiction Cure?

15 Jan • 55 reads

article image

Erythritol Warning: Heart Attack & Stroke Risk

6 Jan • 2 reads

article image

Ozempic Knock-Offs: Are They Safe?

18 Dec, 2025 • 223 reads

article image

Experts Weigh In: When to Stop Antidepressants?

11 Dec, 2025 • 164 reads

article image

GLP-1 Drugs Show No Cancer Risk Reduction

10 Dec, 2025 • 222 reads